Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Center for Research and Development, Poland | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The attendance rate to population based primary screening colonoscopy within NordICC trial (The Nordic-European Initiative on Colorectal Cancer, NCT00883792) in Poland is roughly 33%. The aim of this study is to compare the effect of two different time schedules for sending invitations and reminding letters to a pre-specified colonoscopy appointment. 1,600 screening naive men and women 55 to 64 years of age are randomly assigned in a 1:1 ratio to receive invitation and reminder 6 and 3 weeks (SIX and THREE group) or 4 and 2 weeks (FOUR and TWO group) prior to pre-specified screening colonoscopy appointment date. Outcome measures are participation in screening colonoscopy within 6 months from the date of invitation, response and acceptance rate before sending a reminder. The study is powered to detect 7% difference in participation in screening colonoscopy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Six and three time schedule | Experimental |
| |
| Four and two time schedule | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Six and three time schedule | Other | Invitation letter sent 6 weeks and reminder 3 weeks before a pre-specified screening colonoscopy appointment date. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Participation rate | Percentage of attenders to screening colonoscopy. | 6 months from the date of sending invitation letter |
| Measure | Description | Time Frame |
|---|---|---|
| Acceptance rate in SIX &THREE group | Percentage of invitees who agreed (by phone or letter) to participate in screening colonoscopy before sending a reminder | 3 weeks from the date of sending invitation letter |
| Acceptance rate in FOUR&TWO group |
Not provided
Inclusion criteria:
Individuals aged 55-64 years living in Warsaw area randomly drawn from Population Registry and randomized to the screening arm of the NordICC trial.
Exclusion criteria:
Exclusion criteria for colonoscopy:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Regula Jaroslaw, MD, PhD | Center of Oncology UInstitute and the Maria Sklodowska-Curie | Study Director |
| Kaminski F Michal, MD | Center of Oncology Institute and the Maria Sklodowska-Curie | Study Chair |
| Pisera Malgorzata, Msc | Center of Oncology Institute and the Maria Sklodowska-Curie | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center of Oncology Institute and the Maria Sklodowska-Curie | Warsaw | W.K.Roentgena | 02-781 | Poland |
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Four and two time schedule | Other | Invitation letter and reminder sent 4 and 2 weeks before pre-specified screening colonoscopy appointment date. |
|
Percentage of invitees who agreed (by phone or letter) to participate in screening colonoscopy before sending a reminder
| 2 weeks from the date of sending invitation letter, respectively |
| Response rate in SIX&THREE group | Percentage of invitees who responded (by phone or letter) before sending a reminder | 3 weeks from the date of sending invitation letter |
| Response rate in FOUR&TWO group | Percentage of invitees who responded (by phone or letter) before sending a reminder | 2 weeks from the date of sending invitation letter |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |